DCVC BIO
DCVC Bio is a venture capital fund that invests in early-stage life science companies driven by deep-tech approaches. Advances in genetic sequencing, artificial intelligence, and automation are converging to transform existing life sciences technologies and speed the development of new ones. The firm is looking for companies affecting deep technological change in synthetic biology, medicine, and agriculture. DCVC Bio was founded in 2018 and is based in San Francisco, California, United States.
DCVC BIO
Industry:
AgTech Biotechnology Life Science
Founded:
2018-01-01
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-07-20 | Auron Therapeutics | DCVC Bio investment in Series A - Auron Therapeutics | 48 M USD |
2022-07-01 | Sabanto | DCVC Bio investment in Series A - Sabanto | 17 M USD |
2022-04-19 | Unlearn.AI | DCVC Bio investment in Series B - Unlearn.AI | 50 M USD |
2022-03-08 | Creyon Bio | DCVC Bio investment in Series A - Creyon Bio | 40 M USD |
2022-02-23 | Plexium | DCVC Bio investment in Series B - Plexium | 102 M USD |
2021-12-09 | Totus Medicines | DCVC Bio investment in Series A - Totus Medicines | 40 M USD |
2021-10-06 | CH4 Global | DCVC Bio investment in Series A - CH4 Global | 13 M USD |
2021-09-23 | GenEdit | DCVC Bio investment in Series A - GenEdit | 26 M USD |
2021-07-19 | Frontier Medicines | DCVC Bio investment in Series B - Frontier Medicines | 88.5 M USD |
2021-07-15 | Stemson Therapeutics | DCVC Bio investment in Series A - Stemson Therapeutics | 15 M USD |
More informations about "DCVC Bio"
DCVC | Home
DCVC closes $700 million+ in new funds for a healthier planet and healthier lives; releases second-annual Deep Tech Opportunities Report and first-annual DCVC Climate Impact Report Our first dedicated Climate fund and newest DCVC Bio โฆSee details»
DCVC Bio - Crunchbase Investor Profile & Investments
DCVC Bio is a venture capital fund that invests in early-stage life science companies driven by deep-tech approaches. Advances in genetic sequencing, artificial intelligence, and automation are converging to transform existing life โฆSee details»
Serge Messerlian, Operating Partner, DCVC Bio
Before joining DCVC Bio, Serge was CEO of Teon Therapeutics, an immuno-oncology biotech. Prior to that, as President of Janssen Oncology, a division of the Janssen Pharmaceutical Companies of Johnson & Johnson, he set the โฆSee details»
DCVC Bio - Investments, Portfolio & Company Exits - Crunchbase
DCVC Bio 's most notable exits include Chroma Medicine, AbCellera, and BioPhero. Which industries has this organization had the most exits in? Show . Chroma Medicine Chroma โฆSee details»
DCVC Bio Opportunity Fund: Performance - PitchBook
Jan 1, 2022 DCVC Bio Opportunity Fund is a venture capital fund managed by DCVC Bio. The fund is located in San Francisco, California. The fund targets to invest in the biotechnology โฆSee details»
Kiersten Stead, Managing Partner of DCVC Bio, on โฆ
Oct 26, 2022 DCVC is a venture capital firm based in the West Coast that focuses on deep tech investing, and has over $3B in assets under management. DCVC Bio is the bio focused fund of DCVC, where KierstenโฆSee details»
DCVC Bio | LinkedIn
DCVC Bio | 2,071 followers on LinkedIn. Deep Tech Life Sciences | DCVC Bio invests in early stage deep tech startups in the life sciences. These include therapeutics platforms, companies โฆSee details»
DCVC Bio II: Fund Performance - PitchBook
DCVC Bio II General Information Description. DCVC Bio II is a 2020 vintage venture capital fund managed by DCVC Bio. The fund is located in San Francisco, California, and will invest in the โฆSee details»
MycoWorks | DCVC Job Board
DCVC. Companies. About. DCVC BIO. team. News & Insights. Careers. Open Menu. Careers. Our companies are made up of insanely talented people driven to change the world โ and โฆSee details»
Umoja secures $100m to advance CAR-T cell therapy โฆ
Jan 15, 2025 Double Point Ventures and DCVC Bio jointly led the financing round. January 15, 2025. Share Copy Link; Share on X; Share on Linkedin; Share on Facebook; The financing round is set to propel the advancement of the โฆSee details»
Series A - AgZen - 2025-03-06 - Crunchbase Funding Round Profile
Mar 6, 2025 AgZen raised $10000000 on 2025-03-06 in Series A. DCVC Bio DCVC Bio is a venture capital fund that invests in early-stage life science companies driven by deep-tech โฆSee details»
Elo Life Systems Announces Oversubscribed $20.5 Million Series โฆ
Jan 24, 2024 DCVC Bio, based in San Francisco, backs companies building computationally advantaged or biologically transformative platforms with the potential to dramatically โฆSee details»
Steve Crossan, Operating Partner - DCVC
Prior to joining DCVC, Steve helped GSK to build out their AI organization focused on early discovery. Before that, Steve led the product team responsible for putting British AI research โฆSee details»
John Hamer, PhD | Umoja Biopharma
John is a Managing Partner at DCVC Bio. Prior to joining DCVC, John was a VP at Monsanto and Managing Director of Monsanto Growth Ventures (MGV). Before joining MGV, John was a โฆSee details»
Manager - AR & Revenue Operations @ Pivot Bio | DCVC Job Board
Fueled by an innovative drive and a deep understanding of microbiology, genomics, crop nutrition and agriculture, Pivot Bio is pioneering game-changing advances in fertilizer technology. Our โฆSee details»
General Counsel @ Carbon Health | DCVC Job Board
Carbon Health is a leading national healthcare provider with a mission to make high-quality healthcare accessible to everyone. We offer primary and urgent care to nearly two-thirds of the โฆSee details»
DCVC | Climate techโs lemons-to-lemonade moment: how the โฆ
Nov 12, 2024 DCVC Bio. Team. News & Insights. Careers. Search DCVC Search. Search Open Menu. News & Insights Thoughts. Climate techโs lemons-to-lemonade moment: how the โฆSee details»
Senior Manager, Field Engineering (Pre-Sales) @ Databricks
Jan 16, 2025 Your experience partnering with the sales organization will help close revenue with the right approach whilst coaching new sales and pre-sales teams to work together. You will โฆSee details»
Establishing Canadaโs first large-scale bioinnovation centre
2 days ago Today, the Honourable Darren Fisher, Member of Parliament for Dartmouth โ Cole Harbour, announced a $5 million, non-repayable contribution to Neptune BioInnovation Inc. to โฆSee details»
(Sr.) Manager, Facilities @ Orca Bio | DCVC Job Board
Search job openings across the DCVC network. The (Sr.) Manager, Facilities is responsible for overseeing and maintaining the physical tenant infrastructure, operating all utility systems โฆSee details»